Co-Diagnostics, Inc. Announces Recent Grant Awards The Company intends to use funds awarded by the Bill & Melinda Gates Foundation toward completion of tuberculosis and HPV tests for its Co-Dx PCR Home™ platform  SALT LAKE CITY, July 18, 2023 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX)[1] (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, … Continue reading ALERT! Co-Dx will use Gates Foundation funds to complete TB and HPV tests on its platform.